Astra Group and Kimia Farma Support the ‘Gotong Royong’ Vaccination Program

Promoting Herd Immunity for a Socially and Economically Productive Indonesia

JAKARTA, 19 May 2021 – As many as 2,000 Astra Group employees from PT Astra Otoparts Tbk (AOP) and PT United Tractors Tbk (UT) received vaccinations supported by PT Kimia Farma Tbk through the Gotong Royong Vaccination program. It is the initial phase of vaccinations planned for more than 300,000 Astra Group’s employees and their family members throughout Indonesia following the availability of vaccines coordinated by the Indonesian Chamber of Commerce and Industry (Kadin). As per the government instruction, Kimia Farma would be responsible for supplying the vaccines, including to Astra Group.

The kick-off of the employee vaccination program was held yesterday (18/5) in the Jababeka Industrial Estate, Cikarang, West Java. The President of the Republic of Indonesia Joko Widodo, observed the implementation in person. He was accompanied by the Minister of Trade of the Republic of Indonesia Muhammad Lutfi, Minister of Investment of the Republic of Indonesia Bahlil Lahadalia, Chairman of the Indonesian Chamber of Commerce and Industry (Kadin) Rosan P. Roeslani, and West Java Governor Ridwan Kamil.

At this initial phase, a total of 18 companies, including AOP and UT, participated in the Gotong Royong Vaccination program simultaneously.

“Astra Group welcomes the Gotong Royong COVID-19 Vaccination program for Employees that began yesterday because the health and safety of employees have always been the Company’s top priority since the beginning of the COVID-19 pandemic. We hope that Astra Group’s participation can help the government in accelerating the realization of herd immunity to support the national economic recovery,” said Astra’s President Director Djony Bunarto Tjondro.

Kimia Farma, through its subsidiary, PT Kimia Farma Diagnostika (KFD), was the healthcare provider in the Gotong Royong Vaccination for AOP and UT employees and their family members.

The vaccination of AOP and UT employees ran smoothly with strict health protocols. Vaccination officers from KFD conducted antigen swab tests before the vaccination. This process was also carried out under strict standard operating procedures (SOPs) to ensure that vaccination providers and recipients were in good health.

“Kimia Farma provides the best service in accordance with the SOP in the implementation of the Gotong Royong Vaccination program across Indonesia. We are grateful to Astra Group for entrusting us as the healthcare provider for this vaccination program. We provide the best service for Astra Group and ensure that we provide similar services for employees/workers of other companies that have collaborated with Kimia Farma and their family members. At the same time, we contribute to realizing herd immunity in the community and protecting people from COVID-19 so that they remain socially and economically productive,” said President Director of PT Kimia Farma Tbk Verdi Budidarmo in a press release today (19/5).

Kimia Farma prepared a digital service to ensure that the implementation of the Gotong Royong Vaccination program ran conveniently and safely.

Under this service, vaccinations participant need to first log in to the Kimia Farma Mobile application and enter their data of email address/phone number that their companies have registered. To view a reservation, participants need to select the history menu and click on vaccination.

The third step is the Registration QR Code. To get a code, participants need to fill out a pre-vaccination screening questionnaire 2 hours ahead of the scheduled appointment. The fourth step is getting vaccinated: Participants go through the entire series of examinations up to inoculation. Participants will be inoculated using vaccines determined by the government. Each vaccine injected into each participant will have its vial code scanned to track its authenticity.

The fifth step is observation. Participants need to wait in the observation room for 30 minutes and fill out a post-vaccination questionnaire on the Kimia Farma Mobile application. Participants who experience adverse events following immunization (AEFI) must immediately report to health officers. Finally, the completion step. Participants will receive notification regarding the vaccination certificate via the Kimia Farma Mobile application or SMS.

For further information, please contact:

Boy Kelana Soebroto

Head of Corporate Communications

PT Astra International Tbk

Ph.021-508-43-888

Ganti Winarno P.

Corporate Secretary

PT Kimia Farma Tbk

Jl. Veteran No. 9 Jakarta 10110

Telp. (62-21) – 3847709

About Astra

PT Astra International Tbk was established in 1957 in Jakarta as a general trading company under the name Astra International Inc. In 1990, for the purpose of the company’s initial public offering (IPO), the name of the company changed to PT Astra International Tbk, followed by listing its shares on the Indonesia Stock Exchange under the ticker code ASII.

Astra has developed its business by implementing a business model based on synergies and diversification within seven business divisions: 1) Automotive, 2) Financial Services, 3) Heavy Equipment, Mining, Construction & Energy, 4) Agribusiness, 5) Infrastructure and Logistics, 6) Information Technology and 7) Property.

Astra Group conducts business operations in all parts of Indonesia under the management of more than 238 companies, including subsidiaries, joint ventures and associates, and was supported by more than 188,000 employees, as of March 2021.

As one of the largest national business groups in Indonesia today, Astra has built a strong reputation through offering a range of quality products and services, taking into account the implementation of good corporate and environmental governance. Astra always aspires to be the pride of the nation that participates in efforts to improve the welfare of the Indonesian people.

Astra's business activities strive to apply a balanced mix in the commercial aspects of business and non-business contributions through 9 foundations and a variety of sustainable social responsibility programmes, namely Astra Untuk Indonesia Sehat, Astra Untuk Indonesia Cerdas, Astra Untuk Indonesia Hijau and Astra Untuk Indonesia Kreatif.

Astra initiated the Semangat Astra Terpadu Untuk (SATU) Indonesia Awards programme, which has entered its eleventh year, and has given recognition awards to 397 young Indonesians, consisting of 70 national level recipients and 327 provincial level recipients in the fields of Health, Education, the Environment, Entrepreneurship and Technology, which are integrated with Astra’s wide range of community activities through 116 Kampung Berseri Astra and 755 Desa Sejahtera Astra initiatives in 34 provinces throughout Indonesia.

For further information, please visit www.astra.co.id & www.satu-indonesia.com, and follow Astra through Instagram (@satu_Indonesia), Youtube (SATU Indonesia), Facebook (Semangat Astra Terpadu) and Twitter (@satu_Indonesia).

About Kimia Farma

Kimia Farma is the first pharmaceutical industry company in Indonesia which was founded by the Dutch East Indies Government in 1817. The name of the company was initially NV Chemicalien Handle Rathkamp & Co.

Based on the nationalization of former Dutch companies at the beginning of independence, in 1958, the Government of the Republic of Indonesia merged a number of pharmaceutical companies into PNF (State Pharmaceutical Company) Bhinneka Kimia Farma. Then on August 16, 1971, the legal entity form of PNF was changed to a Limited Liability Company, so that the company's name changed to PT Kimia Farma (Persero).

Listed its initial public shares (IPO) on July 4, 2001, with the issuer code KAEF, and the composition of shares is 90.025% owned by the government and 9.975% owned by the public. Through the inbreng process carried out by the Government of the Republic of Indonesia on February 28, 2020, share ownership of 4,999,999,999 series B shares was transferred to PT Bio Farma (Persero)

Based on Minister of Health Regulation Number 10/2021 concerning the Implementation of Vaccination in the Context of Combating the Corona Virus Disease 2019 (Covid-19) Pandemic, the government assigned PT Bio Farma (Persero) to distribute the Covid-19 vaccine, supporting equipment and logistics. The government can also directly appoint business entities in the distribution of the vaccine.

Meanwhile, companies that will participate in the Gotong Royong Vaccination must first be registered with the Indonesian Chamber of Commerce and Industry. Furthermore, Kadin cooperates with Bio Farma through its subsidiary PT Kimia Farma Tbk. In distributing and injecting the Mutual Cooperation Vaccination, the pharmaceutical issuer with the stock code of KAEF appointed the grandson of success, PT Kimia Farma Diagnostika. Kimia Farma Diagnostika is a subsidiary of PT Kimia Farma Apotek.

Gotong Royong Vaccination is a vaccination program for employees/women, families, and other individuals related to the family whose funding is borne by legal entities/business entities. Since mid-January 2021, the government has held a free Vaccination Program for priority groups such as health workers and the elderly.